Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — August 2024

Biotek-snakken — August 2024

Planlagt Fastgjort Låst Flyttet Biotek-snakken
113 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • exitnuE Offline
    exitnuE Offline
    exitnu
    wrote on sidst redigeret af
    #73

    God morgen 🙂

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #74

      Genovis Announces Strategic Divestment of Antibody Business to Leinco Technologies Inc.

      Link Preview Image
      Genovis Announces Strategic Divestment of Antibody Business to Leinco Technologies Inc.

      Genovis, a leading innovator in enzyme technology, today announced the successful divestment of its

      favicon

      News Powered by Cision (news.cision.com)

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #75

        Genovis AB: Half-Yearly Report January - June 2024

        Link Preview Image
        Half-Yearly Report January - June 2024

        A stable quarter despite subdued market conditions April – June 2024 · Net sales totaled

        favicon

        News Powered by Cision (news.cision.com)

        1 Reply Last reply
        0
        • exitnuE Offline
          exitnuE Offline
          exitnu
          wrote on sidst redigeret af
          #76

          ... det eneste positive (men godt!) er den stigende likviditet: MSEK 135,8.

          1 Reply Last reply
          0
          • X Offline
            X Offline
            xyzabc
            wrote on sidst redigeret af
            #77

            Godmorgen!

            1 Reply Last reply
            0
            • X Offline
              X Offline
              xyzabc
              wrote on sidst redigeret af
              #78

              Egetis Therapeutics AB -New data shows tiratricol (Emcitate®) treatment in patients with MCT8 deficiency is associated with survival benefits (https://www.egetis.com/mfn_news/new-data-shows-tiratricol-emcitate-treatment-in-patients-with-mct8-deficiency-is-associated-with-survival-benefits/)

              1 Reply Last reply
              0
              • X Offline
                X Offline
                xyzabc
                wrote on sidst redigeret af
                #79

                Kan Egetis Therapeutics nå at gøre brug af den "Tranche B" finansering der udløber d. 30. sep. 2024 jf. Q1 2024 eller kunne de risikere en nyemission? https://storage.mfn.se/c5f505c7-a58b-48a3-bc29-596da4764331/q1-2024-report-eng-240502-final3.pdf

                1 Reply Last reply
                0
                • exitnuE Offline
                  exitnuE Offline
                  exitnu
                  wrote on sidst redigeret af
                  #80

                  Danske Bank sänker riktkursen för Genovis till 34 kronor (38), upprepar köp - BN

                  1 Reply Last reply
                  0
                  • exitnuE Offline
                    exitnuE Offline
                    exitnu
                    wrote on sidst redigeret af
                    #81

                    Redeye sänker motiverat värde för Genovis till 52 kronor (65)

                    1 Reply Last reply
                    0
                    • exitnuE Offline
                      exitnuE Offline
                      exitnu
                      wrote on sidst redigeret af
                      #82

                      Genovis Q2 2024: Focusing fully on the enzyme business

                      Just a moment...

                      favicon

                      (www.redeye.se)

                      "Consequently, our updated fair value range amounts to SEK24-102, with a base case of SEK52."

                      1 Reply Last reply
                      0
                      • F Offline
                        F Offline
                        Fandel
                        wrote on sidst redigeret af
                        #83

                        Godmorgen...

                        1 Reply Last reply
                        0
                        • F Offline
                          F Offline
                          Fandel
                          wrote on sidst redigeret af
                          #84

                          Helge jeg synes det er virkelig flot, med den store interesse for Proinvestor. Tillykke med det...

                          1 Reply Last reply
                          0
                          • L Offline
                            L Offline
                            LP90
                            wrote on sidst redigeret af
                            #85

                            Godmorgen 🙂 og stort tillykke med den fantastiske opbakning til dette meget informative site med masser af god faglig input og debat 🙂

                            1 Reply Last reply
                            0
                            • exitnuE Offline
                              exitnuE Offline
                              exitnu
                              wrote on sidst redigeret af
                              #86

                              Genovis ordförande fyller på aktieinnehavet /i går kl. 16:11 ∙ Finwire

                              1 Reply Last reply
                              0
                              • exitnuE Offline
                                exitnuE Offline
                                exitnu
                                wrote on sidst redigeret af
                                #87

                                Vedr.; Infant Bacterial Therapeutics:

                                "The final patient participating in “The Connection Study” is expected to leave the study during July 2024. The results from the study are anticipated during Q3 2024" (April 4, 2024).

                                Dvs. at resultatet forventes senest den kommende måned.

                                1 Reply Last reply
                                0
                                • F Offline
                                  F Offline
                                  Fandel
                                  wrote on sidst redigeret af
                                  #88

                                  Godmorgen...

                                  1 Reply Last reply
                                  0
                                  • F Offline
                                    F Offline
                                    Fandel
                                    wrote on sidst redigeret af
                                    #89

                                    Godmorgen...

                                    1 Reply Last reply
                                    0
                                    • P Offline
                                      P Offline
                                      ProinvestorNEWS
                                      wrote on sidst redigeret af
                                      #90

                                      Weekly Biotech Buzz: AADI Trims R&D Jobs, JNJ Loosens Purse Strings, FDA Snubs REGN's Myeloma Drug https://proinvestor.com/investornyt/1204790/weekly-biotech-buzz-aadi-trims-rampd-jobs-jnj-loosens-purse-strings-fda-snubs-regns-myeloma-drug

                                      1 Reply Last reply
                                      0
                                      • F Offline
                                        F Offline
                                        Fandel
                                        wrote on sidst redigeret af
                                        #91

                                        Godmorgen...

                                        1 Reply Last reply
                                        0
                                        • F Offline
                                          F Offline
                                          Fandel
                                          wrote on sidst redigeret af
                                          #92

                                          Godm
                                          orgen...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper